Edgewise Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-33.5M | $-34.2M | $668.0K | $4.4M |
| FY2022 | $-52.6M | $-58.2M | $5.5M | $10.9M |
| FY2023 | $-91.9M | $-97.7M | $5.7M | $17.6M |
| FY2024 | $-109.0M | $-110.3M | $1.3M | $24.7M |
| FY2025 | $-143.8M | $-144.1M | $256.0K | $34.8M |